DATROWAY
NDC 65597-801, Datopotamab Deruxtecan, injection, powder, lyophilized, for solution, from Daiichi Sankyo Inc..
- Product NDC
- 65597-801
- Status
- Listed
- Labeler
- Daiichi Sankyo Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761394
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65597-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DATOPOTAMAB DERUXTECAN100 mg/5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65597-801-01 | 65597080101 | 1 VIAL, SINGLE-DOSE in 1 CARTON (65597-801-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2950227c-6230-4ca4-a135-46e44d9424a0Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65597-801
Use it
Look up 65597-801 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65597-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65597-801. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.